> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Bipartisan Drug Supply Chain Bill Introduced
- URL: https://www.fdaweb.com/bipartisan-drug-supply-chain-bill-introduced/
- Published: 2021-09-30T12:00:00.000Z
- Updated: 2026-09-14T17:16:56.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5150265

Reps. **David McKiney** (R-WV) and **Abigail Spanberger** (D-VA) have introduced the Promoting Readiness and Ensuring Proper Active Pharmaceutical Ingredient Reserves of Essential Medicines (PREPARE Act) to create an emergency supply of ingredients used in the manufacturing of vital generic medicines and to incentivize domestic manufacturing of these ingredients. McKinley [says](https://mckinley.house.gov/news/documentsingle.aspx?DocumentID=3159&ref=fdaweb.com) (includes links to bill analysis and text) the bill would require HHS to compile a list of essential generic medicines and build out a domestic supply of all the active pharmaceutical ingredients to produce those medicines, with a preference for manufacturers within the U.S.

He says the bill specifically would: 

- require HHS to establish and make public a list of essential generic medicines that are medically necessary to have available at all times;
- create a national stockpile of APIs for the essential medicines to further bolster U.S. emergency preparedness capacity;
- establish a plan to store, track, test, and convert APIs stored in the reserve into finished dosage form and strengthen U.S. capacity for API production; and
- cut red tape that could prevent a manufacturer from ramping up production in an emergency.

Identical legislation is being led in the Senate by Sens. **Sherrod Brown** (D-OH) and **Bill Cassidy** (R-LA), McKinley says.